The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Primary aldosteronism (PA) is the most common cause of secondary hypertension. The aim
of this study was to review the clinical outcomes after mineralocorticoid receptor (MR) …

Objective: To develop a prediction model for clinical outcomes after unilateral
adrenalectomy for unilateral primary aldosteronism. Summary Background Data: Unilateral …

Background: This systematic review and metanalysis was conducted to assess differences
between perioperative and functional outcomes in patients undergoing minimally-invasive …

Primary aldosteronism (PA) can be sporadic or familial and classified into unilateral and
bilateral forms. Sporadic PA predominates with excessive aldosterone production usually …

Background Determination of success after adrenal-sparing surgery for primary
aldosteronism (PA) is limited by the lack of standardized definitions of outcomes. Objective …

Context Adrenal venous sampling (AVS), with or without adrenocorticotropic hormone
(ACTH) stimulation, is the test of choice to identify patients with a surgically curable subtype …

Background Primary hyperaldosteronism is a recognized risk factor for myocardial infarction,
stroke, and atrial fibrillation. Minimally invasive adrenalectomy is the first-line treatment for …

Background Primary aldosteronism (PA) is the most common cause of secondary
hypertension. Surgery is the mainstay of treatment for unilateral dominant PA, but reported …

Objectives Patients with primary aldosteronism (PA) have cardiac remodeling due to
hemodynamic and non-hemodynamic causes. However, component analysis of cardiac …